Efficacy of intravenous verapamil in arterial hypertension refractory to three-step antihypertensive therapy
Language English Country Czech Republic Media print
Document type Journal Article
PubMed
1810700
Knihovny.cz E-resources
- MeSH
- Antihypertensive Agents administration & dosage MeSH
- Clonidine administration & dosage MeSH
- Adult MeSH
- Echocardiography drug effects MeSH
- Ventricular Function, Left drug effects MeSH
- Hemodynamics drug effects MeSH
- Hydrochlorothiazide administration & dosage MeSH
- Hypertension diagnostic imaging drug therapy MeSH
- Infusions, Intravenous MeSH
- Middle Aged MeSH
- Humans MeSH
- Methyldopa administration & dosage MeSH
- Nifedipine administration & dosage MeSH
- Hypertension, Renal diagnostic imaging drug therapy MeSH
- Verapamil administration & dosage MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Antihypertensive Agents MeSH
- Clonidine MeSH
- Hydrochlorothiazide MeSH
- Methyldopa MeSH
- Nifedipine MeSH
- Verapamil MeSH
Intravenous verapamil infusion reduced the arterial pressure (AP) in 13 out of 71 (76.5%) patients with severe arterial hypertension (AH) refractory to a two-week, three-step oral antihypertensive medication. Investigations including echo- and radio-cardiography were performed: in the control period before starting the three-step treatment; after two weeks before intravenous verapamil infusions; 10 days after stopping the verapamil administration, and before leaving the hospital during continued 3-4 weeks three-step therapy. The AP reduction was caused by decreased total peripheral resistance. Verapamil administration improved also intracardiac haemodynamics and left ventricular contraction. The AP was effectively controlled even after stopping the verapamil administration and continuing the three-step oral antihypertensive treatment. No manifest changes in the left ventricular function were registered.